Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gamma Vision is a medical technology company specializing in advanced ophthalmic diagnostic solutions. The company's primary offering is the Gamma Vision System, a non-invasive imaging platform designed for the early detection and monitoring of retinal diseases such as glaucoma and macular degeneration. By utilizing proprietary imaging algorithms and high-resolution sensors, the technology provides clinicians with detailed functional and structural data of the eye. Gamma Vision aims to improve patient outcomes through earlier intervention and more precise disease management in the field of ophthalmology. The company serves eye care professionals globally with its diagnostic hardware and integrated software services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gamma Vision.